Protagonist Therapeutics
PTGX
PTGX
66 hedge funds and large institutions have $226M invested in Protagonist Therapeutics in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
9.71% more ownership
Funds ownership: 48.08% → 57.79% (+9.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$18.7M | |
| 2 | +$11.2M | |
| 3 | +$8.31M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$6.12M |
| 5 |
DM
Deerfield Management
New York
|
+$4.68M |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$2.08M | |
| 3 | -$853K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$178K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$85K |